References
- Dickinson R.G., Hooper W.D., Eadie M.J. pH-Dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug Metabolism and Disposition 1984; 12: 247–252
- Fisher L.J., Thies R.L., Charkowski D., Donham K.J. Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans. Drug Metabolism and Disopsition 1980; 8: 422–424
- Hamill S., Cooper D.Y. The role of cytochrome P-450 in the dual pathways of N-demethylation of N,N'-dimethylaniline by hepatic microsomes. Xenobiotica 1984; 14: 139–149
- Hasegawa J., Smith P.C., Benet L.Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metabolism and Disposition 1982; 10: 469–473
- Hayakawa I., Hiramitsu T., Tanaka Y. Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acids. Chemical Pharmaceutical Bulletin 1984; 32: 4907–4913
- Ichihara N., Tachizawa H., Tsumura M., Une T., Sato K. Phase I study on DL-8280. Chemotherapy 1984; 32(s–1)118–149
- Illing H.P.A., Wilson L.D. pH Dependent formation of β-glucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. Biochemical Pharmacology 1981; 30: 3381–3384
- Janssen F.W., Kirkman S.K., Fenselau C., Stogniew M., Hofmann B.R., Young E.M., Ruelius H.W. Metabolic formation of N- and O-glucuronides of 3-(p-chloro-phenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-O-acyl glucuronide. Drug Metabolism and Disposition 1982; 10: 599–604
- Kloss M.W., Rosen G.M., Rauckman E.J. N-Demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Molecular Pharmacology 1983; 23: 482–485
- Lehman J.P., Fenselau C., Depaulo J.R. Quaternary ammonium-linked glucuronides of amitriptyline, imipramine, and chlorpromazine. Drug Metabolism and Disposition 1983; 11: 221–225
- Okazaki O., Kurata T., Hashimoto K., Sudo K., Tsumura M., Tachizawa H. Metabolic disposition of DL-8280. The second report: absorption, distribution and excretion of 14C-DL-8280 in various animal species. Chemotherapy 1984; 32(s–1)1185–1202
- Sato K., Matsuura Y., Inoue M., Une T., Osada Y., Ogawa H., Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrobial Agents and Chemotherapy 1982; 22: 548–553
- Sudo K., Hashimoto K., Kurata T., Okazaki O., Tsumura M., Tachizawa H. Metabolic disposition of DL-8280. The third report: metabolism of 14C-DL-8280 in various animal species. Chemotherapy 1984; 32(s–1)1203–1210
- Testa B., Jenner P. Novel drug metabolites produced by functionalization reaction: chemistry and toxicology. Drug Metabolism Reviews 1978; 7: 325–369
- Windholz M., Budavari S., Blumetti R.F., Otterbein E.S. The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals, 10th ed. Merck & Co., Inc., Rahway 1983, organic name reactions-28
- Ziegler D.M., Mitchell C.H. Microsomal oxidase IV: properties of a mixed-function amine oxidase isolated from pig liver microsomes. Archives of Biochemistry and Biophysics 1972; 150: 116–125